1195P Brigatinib (BRG) Vs Crizotinib (CRZ) in ALK TKI–naive ALK+ NSCLC: Final Results from ALTA-1LS. Popat,H.R. Kim,M-J. Ahn,J.C. Yang,J-Y. Han,M.J. Hochmair,K.H. Lee,A. Delmonte,M.R. Garcia Campelo,D-W. Kim,F. Griesinger,E. Felip,R. Califano,A. Spira,S.N. Gettinger,M. Tiseo,H.M. Lin,Y. Liu,F. Vranceanu,D.R. CamidgeAnnals of oncology(2021)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要